Java Ijen Plateau Coffee (Coffea arabica 'Java Ijen Plateau')

Java Ijen Plateau coffee is an Arabica cultivar grown at high altitude in East Java, Indonesia, containing caffeine and chlorogenic acids as its primary bioactive compounds. These compounds act on adenosine receptors and modulate glucose metabolism, though no studies have isolated health effects specific to this geographic variety.

Origin & History

Java Ijen Plateau coffee is an Arabica variety grown on the Ijen Plateau in East Java, Indonesia, at elevations around 1,400 meters on volcanic soil. This specialty coffee is processed using the wet (washed) method, which produces a full-bodied coffee with low acidity and distinctive earthy flavor notes including chocolate, nuts, and spice.

Historical & Cultural Context

No traditional medicinal or cultural health uses documented in the available research. Sources describe Java Ijen Plateau coffee solely in the context of specialty coffee production and flavor profiles.

Health Benefits

• No clinical health benefits documented - search results contain only beverage descriptions, not biomedical research
• No peer-reviewed studies found examining health effects specific to this cultivar
• No evidence of bioactive compounds unique to Java Ijen Plateau variety
• No traditional medicinal uses documented in available sources
• No clinical trials or epidemiological data available for this specific coffee variant

How It Works

Caffeine, typically 1–2% by dry weight in Arabica beans, competitively antagonizes adenosine A1 and A2A receptors in the central nervous system, reducing perceived fatigue and increasing dopaminergic signaling. Chlorogenic acids, including 5-caffeoylquinic acid, inhibit glucose-6-phosphatase and slow intestinal glucose absorption, contributing to postprandial glycemic modulation. Diterpenes cafestol and kahweol found in unfiltered preparations activate pregnane X receptor and modulate cholesterol metabolism via LDL receptor downregulation.

Scientific Research

No clinical trials, randomized controlled trials, or meta-analyses were found in the research dossier. The available sources treat Java Ijen Plateau coffee exclusively as a specialty beverage product rather than a studied biomedical ingredient.

Clinical Summary

No clinical trials or pharmacological studies have been conducted specifically on Java Ijen Plateau coffee as a distinct cultivar or supplement ingredient. Evidence for its bioactive compounds is extrapolated from general Arabica coffee research; a 2014 meta-analysis (Ding et al., Diabetes Care) of 28 prospective studies found habitual coffee consumption associated with reduced type 2 diabetes risk, but cultivar-specific data are absent. Chlorogenic acid trials using standardized green coffee extract (e.g., 400 mg doses in Thom 2007, n=30) showed modest blood pressure reductions, though these used concentrated extracts rather than brewed Ijen coffee. Overall evidence strength for this specific variety is negligible; any attributed benefits are inferred from broader Arabica coffee literature.

Nutritional Profile

{"macronutrients": {"protein": "Approximately 0.3g per 100ml brewed coffee", "fiber": "Negligible in brewed coffee"}, "micronutrients": {"vitamins": {"Vitamin B2 (Riboflavin)": "0.01mg per 100ml brewed coffee", "Vitamin B3 (Niacin)": "0.5mg per 100ml brewed coffee"}, "minerals": {"Magnesium": "7mg per 100ml brewed coffee", "Potassium": "116mg per 100ml brewed coffee"}}, "bioactive_compounds": {"Caffeine": "40mg per 100ml brewed coffee", "Chlorogenic acids": "70mg per 100ml brewed coffee"}, "bioavailability_notes": "The bioavailability of caffeine and chlorogenic acids can vary based on brewing methods and individual metabolic differences. Minerals and vitamins are present in low concentrations and contribute minimally to daily intake."}

Preparation & Dosage

No clinically studied dosage ranges available. No standardization protocols or biomedical preparation methods documented. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of biomedical research

Safety & Interactions

Caffeine from this coffee can cause insomnia, tachycardia, anxiety, and elevated blood pressure at intakes exceeding 400 mg per day in healthy adults, per FDA guidance. It interacts with adenosine-modifying drugs, MAO inhibitors, and anticoagulants such as warfarin by altering hepatic CYP1A2 enzyme activity, potentially altering drug plasma levels. Pregnant individuals are advised to limit caffeine to under 200 mg per day (WHO/ACOG), as higher intake is associated with reduced fetal birth weight. Individuals with cardiac arrhythmias, severe hypertension, or anxiety disorders should exercise caution with any caffeinated coffee product.